Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Cohort 1: ARQ-252 Cream 0.3% QD | Participants applied ARQ-252 cream 0.3% QD to both hands for 2 weeks. | 0 | None | 0 | 7 | 0 | 7 | View |
| Cohort 2: ARQ-252 Cream 0.3% QD | Participants applied ARQ-252 cream 0.3% QD to both hands for 12 weeks. | 0 | None | 0 | 65 | 2 | 65 | View |
| Cohort 2: ARQ-252 Cream 0.3% BID | Participants applied ARQ-252 cream 0.3% BID to both hands for 12 weeks. | 0 | None | 0 | 61 | 2 | 61 | View |
| Cohort 2: ARQ-252 Cream 0.1% QD | Participants applied ARQ-252 cream 0.1% QD to both hands for 12 weeks. | 0 | None | 0 | 32 | 3 | 32 | View |
| Cohort 2: Vehicle Cream QD | Participants applied ARQ-252 Vehicle Cream QD to both hands for 12 weeks. | 0 | None | 0 | 33 | 2 | 33 | View |
| Cohort 2: Vehicle Cream BID | Participants applied ARQ-252 Vehicle Cream BID to both hands for 12 weeks. | 0 | None | 0 | 32 | 1 | 32 | View |